Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 625-634

  Banegas, Matthew P ^a   Tao, Li ^b   Altekruse, Sean ^a   Anderson, William F ^a   John, Esther M ^b,c   Clarke, Christina A ^b,c   Gomez, Scarlett L ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Hispanic; Latina; Socioeconomic status; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENETIC HETEROGENEITY; HIGH RISK PATIENT; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POLYTOMOUS LOGISTIC REGRESSION; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SOCIAL STATUS; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALIFORNIA; FEMALE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK FACTORS; SURVIVAL ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84899493564     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2882-1     Document Type: Article

References (42)

1. Banegas MP, Li CI (2012) Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat 134(3):1297-1304. doi:10.1007/s10549-012-2142-1
2. Ooi SL, Martinez ME, Li CI (2010) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. doi:10.1007/s10549-010-1191-6
3. Parise CA, Bauer KR, Brown MM, Caggiano V (2009) Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 TBJ822. Breast J 15(6):593-602. doi:10.1111/j.1524-4741.2009.00822.x
4. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502 (Pubitemid 43854964)
5. Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6. doi:10.1186/bcr1639
6. Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M (2011) Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Womens Health (2002) 20(10):1543-1550. doi:10.1089/jwh 2010.2558
7. Ortiz AP, Frias O, Perez J, Cabanillas F, Martinez L, Sanchez C, Capo-Ramos DE, Gonzalez-Keelan C, Mora E, Suarez E (2013) Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico. Cancer Med 2(3):343-350. doi:10.1002/cam4.78
8. Gomez SL, Le GM, West DW, Satariano WA, O'Connor L (2003) Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace. Am J Public Health 93(10):1685-1688 (Pubitemid 38477635)
9. North American Association of Central Cancer Registries (NAACCR) Race and Ethnicity Work Group NAACCR Guideline for Enhancing Hispanic/Latino Identification: Revised NAACCR Hispanic/Latino Identification Algorithm [NHIA v2.2]. North American Association of Central Cancer Registries, Springfield, IL
10. Gomez SL, Quach T, Horn-Ross PL, Pham JT, Cockburn M, Chang ET, Keegan TH, Glaser SL, Clarke CA (2010) Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status. Am J Public Health 100(Suppl 1):S125-S131. doi:10.2105/AJPH.2009.163931
11. Gomez SL, Glaser SL (2005) Quality of cancer registry birthplace data for Hispanics living in the United States. Cancer Causes Control 16(6):713-723. doi:10.1007/s10552-005-0694-7 (Pubitemid 41110962)
12. Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104(14):1094-1101. doi:10.1093/jnci/djs264
13. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109(9):1721-1728 (Pubitemid 46668532)
14. Bernstein L, Lacey JV Jr (2011) Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? J Natl Cancer Inst 103(6):451-453. doi:10.1093/jnci/djr046
15. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784-2795. doi:10.1200/JCO.2009. 25.6529
16. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145 (Pubitemid 350003059)
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752
18. Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142(8):796-803
19. Andaya AA, Enewold L, Horner MJ, Jatoi I, Shriver CD, Zhu K (2012) Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control 23(6):951-958. doi:10.1007/s10552-012-9966-1
20. Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22(1):55-65
21. Drewnowski A, Specter SE (2004) Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr 79(1):6-16 (Pubitemid 41132056)
22. Gordon-Larsen P, Nelson MC, Page P, Popkin BM (2006) Inequality in the built environment underlies key health disparities in physical activity and obesity. Pediatrics 117(2):417-424. doi:10.1542/peds.2005-0058 (Pubitemid 46071604)
23. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Scarmo S, Schairer C, Schouten LJ, Shikany JM, Sieri S, Tsugane S, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG, Smith-Warner SA (2013) Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 105(3):219-236. doi:10.1093/jnci/ djs635
24. Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA (2012) Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 95(3):713-725. doi:10.3945/ajcn.111.014415
25. Wu Y, Zhang D, Kang S (2013) Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 137(3):869-882. doi:10.1007/s10549-012-2396-7
26. Vona-Davis L, Rose DP, Hazard H, Howard-McNatt M, Adkins F, Partin J, Hobbs G (2008) Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev 17(12):3319-3324. doi:10.1158/1055-9965.EPI-08-0544
27. Heck KE, Braveman P, Cubbin C, Chavez GF, Kiely JL (2006) Socioeconomic status and breastfeeding initiation among California mothers. Public Health Rep 121(1):51-59 (Pubitemid 43200187)
28. Martinez GM, Chandra A, Abma JC, Jones J, Mosher WD (2006) Fertility, contraception, and fatherhood: data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital Health Stat 23(26):1-142
29. Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE (2013) Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 137(2):579-587. doi:10.1007/s10549-012-2365-1
30. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103(6):470-477. doi:10.1093/jnci/djr030
31. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123-139. doi:10.1007/s10549-007-9632-6 (Pubitemid 351538762)
32. Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health 18(6):883-893. doi:10.1089/jwh2008.1127
33. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15 Pt 1):4429-4434. doi:10.1158/1078-0432.CCR-06-3045 (Pubitemid 47219710)
34. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7(1-2):4-13. doi:10.3121/cmr.2009.825
35. Ennis SR, Rios-Vargas M, Albert NG (2011) The Hispanic population: 2010. Census 2010 Briefs
36. Gomez SL, Glaser SL (2004) Quality of birthplace information obtained from death certificates for Hispanics, Asians, and Pacific Islanders. Ethn Dis 14(2):292-295 (Pubitemid 39302873)
37. Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, Schwartz SM, Bernstein L, Chen VW, Goodman MT, Gomez SL, Graff JJ, Lynch CF, Lin CC, Edwards BK (2007) Quality of race, hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18(2):177-187. doi:10.1007/s10552-006-0089-4 (Pubitemid 46215314)
38. Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control 17(6):771-781. doi:10.1007/s10552-006-0013-y
39. Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS (1999) Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota study. J Clin Epidemiol 52(5):447-452 (Pubitemid 29305350)
40. Percy C, Ries LG, Van Holten VD (1990) The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep 105(4):361-367 (Pubitemid 20264619)
41. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR (2000) Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92(9):743-749 (Pubitemid 30365535)
42. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91(23):2020-2028